Work

Impact of zumor mutation burden on nivolumab efficacy in second-line urothelial carcinoma patients: Exploratory analysis of the phase ii checkmate 275 study

Year: 2017

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdx371.003

Authors: M.D. Galsky, A. Saci, P.M. Szabo, A. Azrilevich, C. Horak, A. Lambert, A. Siefker-Radtke, A. Necchi, P. Sharma

Institutions: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Bristol-Myers Squibb (United States), Bristol-Myers Squibb (Belgium), The University of Texas MD Anderson Cancer Center, Fondazione IRCCS Istituto Nazionale dei Tumori

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2763048166

FWCI: 3.57

Cites:

Cited by: 56

Related to: 10